PAQR6 as a prognostic biomarker and potential therapeutic target in kidney renal clear cell carcinoma
BackgroundProgestin And AdipoQ Receptor Family Member VI (PAQR6) plays a significant role in the non-genomic effects of rapid steroid responses and is abnormally expressed in various tumors. However, its biological function in kidney renal clear cell carcinoma (KIRC) and its potential as a therapeut...
Saved in:
| Main Authors: | Tao Zou, Zongming Jia, Jixiang Wu, Xuxu Liu, Minghao Deng, Xuefeng Zhang, Yuxin Lin, Jigen Ping |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1521629/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biochemical characterization of zebrafish Paqr5b
by: Md Sohanur Rahman Sohan, et al.
Published: (2025-06-01) -
Chicoric acid advanced PAQR3 ubiquitination to ameliorate ferroptosis in diabetes nephropathy through the relieving of the interaction between PAQR3 and P110α pathway
by: Weiwei Zhang, et al.
Published: (2024-12-01) -
Downregulation of PAQR3 expression predicts poor prognosis of patients with pan-cancer: a meta-analysis
by: Kui Zhai, et al.
Published: (2025-05-01) -
Transcriptomic and Functional Validation Reveals PAQR3/P6-55 as Potential Therapeutic Targets in Colon Cancer
by: Xue You, et al.
Published: (2025-06-01) -
PRSS53 is a potential novel biomarker related to prognosis and immunity in clear cell renal cell carcinoma
by: Jiajun Zhang, et al.
Published: (2025-03-01)